Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
Send Cancel

Concerns raised over remote prescribing guidance
BVA has voiced concerns over several extensions to the guidance and suggested that it could lead to unrealistic expectations among clients.
BVA questions why the temporary guidance appears to be becoming “part of the new normal”.

BVA President Dr Justine Shotton has penned a letter to the RCVS expressing concern over the regulator’s decision to extend measures permitting remote prescribing.

In the letter, Dr Shotton questions why the guidance appears to be becoming “part of the new normal” and calls on the RCVS to share details about the evidence that influenced the extension, as well as the exit plan.
Remote prescribing was introduced by the RCVS as a temporary measure early on in the pandemic to reduce appointments in practice and keep the veterinary team safe while maintaining animal health and welfare. The guidance enables vets to remotely prescribe prescription-only veterinary medicines (POM-Vs) without a physical examination of the animal.

While it initially supported the measures, BVA has voiced concern over several extensions to the guidance and suggested that it could lead to unrealistic expectations among clients. It has also expressed concern over the risks to animal welfare in cases where health problems are not identified during in-practice appointments.

Writing to the RCVS, Dr Shotton quotes the BVA’s new policy stance on under care and the remote provision of veterinary services, which acknowledged the early relaxation of prescribing requirements as a “pragmatic solution”. The position statement added, however, that this was a temporary measure in unprecedented times, which “must not lead to a longer-term change without full consultation with the profession and total transparency in relation to impacts on prescribing behaviours.” 

Dr Shotton concludes: “We would like to better understand the evidence base on which RCVS continues to allow remote prescribing, including the impact on prescribing behaviours, and the proposed exit strategy. As far as we are aware, RCVS is still assessing the findings from the RAND survey as part of the under care review, and as those results are yet to be shared it is unclear how the continual extensions to remote prescribing dovetail with longer-term plans and potential changes to the Code.”

Become a member or log in to add this story to your CPD history

RCVS Fellowship applications open

News Story 1
 Applications have now opened for RCVS Fellowship 2022. The RCVS is encouraging anyone who would like to be considered for Fellowship to apply, and if successful, they will be welcomed into the Fellowship next year.

The process for joining the fellowship has changed slightly for this year, as applicants will now need two signed referee forms instead of three professional references, and five assessors will review each application instead of three.

The deadline for applications is 14 February 2022, and more information on how to apply can be found here. If applicants have any questions, or would like informal advice from previous successful applicants, they are encouraged to contact Ceri Via Email 

Click here for more...
News Shorts
Horiba announces veterinary haematology webinar

Horiba Medical has announced a free webinar providing practical insight on best practice in veterinary haematology. Entitled 'In practice haematology - Beyond the pale!' the webinar will be presented by Ronnie Barron from the University of Glasgow Veterinary School.

Ronnie's presentation, which will conclude with a Q&A session, will look at QC and artefacts of sample quality and review the effects of different pathologies. Using images, photomicrographs and video links, he will also explain the techniques and equipment needed to complement analytical automation to confirm results quality.

The webinar takes place on Thursday, October 28 (7.30-9pm). For more details and to register, click here.